We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+5.26%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$57.2B
AUM Growth
+$551M
(+0.97%)
Cap. Flow
-$331M
Cap. Flow
% of AUM
-0.58%
Top 10 Holdings %
Top 10 Hldgs %
31.76%
Holding
1,006
New
143
Increased
295
Reduced
385
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$247M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$183M |
| 3 |
WCC
WESCO International
WCC
|
+$178M |
| 4 |
Gilead Sciences
GILD
|
+$154M |
| 5 |
Delta Air Lines
DAL
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRO
Marathon Oil Corporation
MRO
|
+$221M |
| 2 |
3M
MMM
|
+$157M |
| 3 |
MRSH
Marsh
MRSH
|
+$120M |
| 4 |
Johnson & Johnson
JNJ
|
+$106M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.09% |
| 2 | Healthcare | 13.87% |
| 3 | Financials | 11.48% |
| 4 | Consumer Discretionary | 10.65% |
| 5 | Industrials | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Bunge Global
BG
$20.8B
| $10.1M | 0.02% |
130,500
-3,000
| -2% | -$263K |
|
|
DAWN
602
DELISTED
Day One Biopharmaceuticals
DAWN
| $10.1M | 0.02% |
800,000
-100,000
| -11% | -$1.39M |
|
603
Highwoods Properties
HIW
$3.56B
| $10.1M | 0.02% |
330,156
+88,648
| +37% | +$2.89M |
|
|
X
604
DELISTED
US Steel
X
| $10.1M | 0.02% |
296,883
-1,125,902
| -79% | -$41.6M |
|
605
Acadia Healthcare
ACHC
$2.95B
| $10.1M | 0.02% |
253,580
+48,013
| +23% | +$2.17M |
|
606
Meritage Homes
MTH
$4.81B
| $10M | 0.02% |
+130,000
| New | +$11.9M |
|
607
Essex Property Trust
ESS
$18.4B
| $9.99M | 0.02% |
35,000
+25,737
| +278% | +$7.6M |
|
608
Burlington
BURL
$23.3B
| $9.98M | 0.02% |
35,000
-35,000
| -50% | -$9.46M |
|
609
Paylocity
PCTY
$8.26B
| $9.97M | 0.02% |
+50,000
| New | +$9.57M |
|
610
Agios Pharmaceuticals
AGIO
$1.92B
| $9.96M | 0.02% |
+303,000
| New | +$14.2M |
|
|
CDTX
611
DELISTED
Cidara Therapeutics
CDTX
| $9.94M | 0.02% |
369,954
+327,199
| +765% | +$5.32M |
|
612
Huntington Ingalls Industries
HII
$12.7B
| $9.93M | 0.02% |
52,530
+15,523
| +42% | +$3.35M |
|
613
Birkenstock
BIRK
$6.84B
| $9.92M | 0.02% |
+175,000
| New | +$8.88M |
|
614
SiteOne Landscape Supply
SITE
$4.39B
| $9.88M | 0.02% |
+75,000
| New | +$10.8M |
|
615
Commerce Bancshares
CBSH
$8.59B
| $9.86M | 0.02% |
+166,126
| New | +$10M |
|
616
Celanese
CE
$4.9B
| $9.83M | 0.02% |
142,100
+39,100
| +38% | +$3.76M |
|
617
LPL Financial
LPLA
$28.3B
| $9.8M | 0.02% |
+30,000
| New | +$8.87M |
|
618
Labcorp
LH
$25.4B
| $9.78M | 0.02% |
+42,644
| New | +$9.78M |
|
619
Ionis Pharmaceuticals
IONS
$9.04B
| $9.61M | 0.02% |
275,000
-225,000
| -45% | -$8.41M |
|
|
PLYM
620
DELISTED
Plymouth Industrial REIT
PLYM
| $9.61M | 0.02% |
+540,000
| New | +$10.7M |
|
621
Yum China
YUMC
$16.4B
| $9.57M | 0.02% |
+198,700
| New | +$9.42M |
|
622
Northwest Natural Holdings
NWN
$2.11B
| $9.54M | 0.02% |
241,242
-138,642
| -36% | -$5.66M |
|
623
Evolent Health
EVH
$425M
| $9.5M | 0.02% |
844,504
-575,883
| -41% | -$10.1M |
|
624
MDU Resources
MDU
$4.26B
| $9.46M | 0.02% |
525,000
+164,000
| +45% | +$2.88M |
|
625
Molson Coors Class B
TAP
$8.03B
| $9.36M | 0.02% |
163,236
-2,400
| -1% | -$140K |
|
Similar funds
Adage Capital Partners's Q4 2024 Portfolio in Review
As of Q4 2024, Adage Capital Partners held 1,006 positions worth $57.2B, up 0.97% from $56.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Adage Capital Partners's Q4 2024 filing shows 143 new, 295 increased, 385 reduced and 137 closed positions. Its largest new stake was Gilead Sciences: 1,714,130 shares worth $158M. The largest sale was Marathon Oil Corporation, an estimated $221M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q4 2024 buy was Gilead Sciences: 1,714,130 shares worth $158M.
- Adage Capital Partners added most to ConocoPhillips in Q4 2024, an estimated $247M increase.
- Adage Capital Partners's biggest Q4 2024 reduction was 3M, cutting an estimated $157M.
- Adage Capital Partners fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $221M.
- Adage Capital Partners's ten largest holdings make up 32% of its $57.2B portfolio in Q4 2024.
- Adage Capital Partners opened 143 new positions and closed 137 in Q4 2024.
- Adage Capital Partners's portfolio value rose 0.97% quarter-over-quarter to $57.2B.
Based on Adage Capital Partners's 13F filing for Q4 2024, filed 14 Feb 2025.